Cargando…

Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease

Background: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease. This study explored the core genes and pathways associated with DKD to identify potential diagnostic and therapeutic targets. Methods: We downloaded microarray datasets GSE96804 and GSE104948 from the Gene Exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Wei, Wang, Ting, Wu, Feng, Zhang, Yiding, Shang, Jin, Zhao, Zhanzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441656/ https://www.ncbi.nlm.nih.gov/pubmed/36071835 http://dx.doi.org/10.3389/fphar.2022.931282

Ejemplares similares

Gut microbiota, key to unlocking the door of diabetic kidney disease
por: Wang, Peipei, et al.
Publicado: (2021)

The gut microbiome in differential diagnosis of diabetic kidney disease and membranous nephropathy
por: Yu, Wei, et al.
Publicado: (2020)

Diagnostic value of α1-MG and URBP in early diabetic renal impairment
por: Zhou, Yukun, et al.
Publicado: (2023)

Development and validation of a predictive model for the progression of diabetic kidney disease to kidney failure
por: Cheng, Yaqi, et al.
Publicado: (2020)

SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway
por: Guo, Ruixue, et al.
Publicado: (2022)

Corrigendum: SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway
por: Guo, Ruixue, et al.
Publicado: (2022)

Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice
por: Wang, Peipei, et al.
Publicado: (2022)

Construction of a Nomogram Discriminating Malignancy-Associated Membranous Nephropathy From Idiopathic Membranous Nephropathy: A Retrospective Study
por: Wang, Ting, et al.
Publicado: (2022)

Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes
por: Dong, Yijun, et al.
Publicado: (2022)

Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast Cancer
por: Bao, Shengnan, et al.
Publicado: (2020)

Identification of Key Biomarkers and Immune Infiltration in Sciatic Nerve of Diabetic Neuropathy BKS-db/db Mice by Bioinformatics Analysis
por: Lin, Yixuan, et al.
Publicado: (2021)

Identification of key lncRNAs contributing to diabetic nephropathy by gene co-expression network analysis
por: Shang, Jin, et al.
Publicado: (2019)

Identification of the key ferroptosis-related genes involved in sepsis progression and experimental validation in vivo
por: Li, Zhixi, et al.
Publicado: (2022)

Identification of Potential Biomarkers for Pan-Cancer Diagnosis and Prognosis Through the Integration of Large-Scale Transcriptomic Data
por: Zhu, Lin, et al.
Publicado: (2022)

Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
por: Gu, Yue-Yu, et al.
Publicado: (2021)

Identifying effective diagnostic biomarkers and immune infiltration features in chronic kidney disease by bioinformatics and validation
por: Liu, Tao, et al.
Publicado: (2022)

Development and validation of a predictive model for end-stage renal disease risk in patients with diabetic nephropathy confirmed by renal biopsy
por: Sun, Lulu, et al.
Publicado: (2020)

The controversy of klotho as a potential biomarker in chronic kidney disease
por: Yu, Li-Xia, et al.
Publicado: (2022)

Identification and validation of SERPINE1 as a prognostic and immunological biomarker in pan-cancer and in ccRCC
por: Li, Lingqin, et al.
Publicado: (2023)

The protective mechanism of Dehydromiltirone in diabetic kidney disease is revealed through network pharmacology and experimental validation
por: Wang, Yanzhe, et al.
Publicado: (2023)

Functional Metabolomics Analysis Elucidating the Metabolic Biomarker and Key Pathway Change Associated With the Chronic Glomerulonephritis and Revealing Action Mechanism of Rhein
por: Yu, Wei, et al.
Publicado: (2020)

Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer
por: Jiang, Huafeng, et al.
Publicado: (2023)

Biomarker identification and pathway analysis of Astragalus membranaceus and Curcuma zedoaria couplet medicines on adenine-induced chronic kidney disease in rats based on metabolomics
por: Lu, Lingfei, et al.
Publicado: (2023)

Evaluation of the efficacy of Abelmoschus manihot (L.) on diabetic nephropathy by analyzing biomarkers in the glomeruli and proximal and distal convoluted tubules of the kidneys
por: Yu, Hongmei, et al.
Publicado: (2023)

Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer’s Disease
por: Dai, Zhao, et al.
Publicado: (2022)

The harmful intestinal microbial community accumulates during DKD exacerbation and microbiome–metabolome combined validation in a mouse model
por: Shang, Jin, et al.
Publicado: (2022)

The critical role of dysregulated autophagy in the progression of diabetic kidney disease
por: Zhang, Ziwei, et al.
Publicado: (2022)

Network Pharmacology for Analyzing the Key Targets and Potential Mechanism of Wogonin in Gliomas
por: Wang, Zaizhong, et al.
Publicado: (2021)

Editorial: Combating Diabetes and Diabetic Kidney Disease
por: Srivastava, Swayam Prakash, et al.
Publicado: (2021)

Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy
por: Wu, Feng, et al.
Publicado: (2021)

Diabetic retinopathy: Involved cells, biomarkers, and treatments
por: Ren, Jiahui, et al.
Publicado: (2022)

Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease
por: Yan, Zhonghong, et al.
Publicado: (2021)

The Identification of the Biomarkers of Sheng-Ji Hua-Yu Formula Treated Diabetic Wound Healing Using Modular Pharmacology
por: Jiang, Jing-Si, et al.
Publicado: (2021)

Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease
por: Zhang, Bo, et al.
Publicado: (2022)

Nephroprotective Effects of Tetramethylpyrazine Nitrone TBN in Diabetic Kidney Disease
por: Jing, Mei, et al.
Publicado: (2021)

Identification of key pharmacodynamic markers of American ginseng against heart failure based on metabolomics and zebrafish model
por: Dong, Rong, et al.
Publicado: (2022)

The construction of a TCM knowledge graph and application of potential knowledge discovery in diabetic kidney disease by integrating diagnosis and treatment guidelines and real-world clinical data
por: Zhao, Xiaoliang, et al.
Publicado: (2023)

Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
por: Meunier, Lucy, et al.
Publicado: (2019)

Potential Metabolic Biomarkers for Early Detection of Oral Lichen Planus, a Precancerous Lesion
por: Wang, Xiao-Shuang, et al.
Publicado: (2020)

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
por: Chen, Yingji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hbo1o8bbnepmbqet79po6d2pe8